GAS6

Growth arrest-specific protein 6 · Q14393 · GAS6 on Sugi Atlas →

9,117 patent compounds predicted against GAS6, 4,088 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL3048653 SCHEMBL3048653 0.51 17/20
SCHEMBL1885183 SCHEMBL1885183 0.51 17/20
SCHEMBL486036 SCHEMBL486036 0.51 17/20
SCHEMBL559524 SCHEMBL559524 0.57 16/20
SCHEMBL2260565 SCHEMBL2260565 0.57 16/20
SCHEMBL559186 SCHEMBL559186 0.50 16/20
SCHEMBL2256601 SCHEMBL2256601 0.50 16/20
SCHEMBL559177 SCHEMBL559177 0.52 15/20
SCHEMBL2258657 SCHEMBL2258657 0.52 15/20
SCHEMBL559165 SCHEMBL559165 0.48 14/20
SCHEMBL558556 SCHEMBL558556 0.45 14/20
SCHEMBL2256894 SCHEMBL2256894 0.45 14/20
SCHEMBL559371 SCHEMBL559371 0.44 14/20
SCHEMBL2256609 SCHEMBL2256609 0.44 14/20
SCHEMBL558202 SCHEMBL558202 0.53 13/20
SCHEMBL2259421 SCHEMBL2259421 0.53 13/20
SCHEMBL3450061 SCHEMBL3450061 0.52 13/20
SCHEMBL3450065 SCHEMBL3450065 0.52 13/20
SCHEMBL559344 SCHEMBL559344 0.48 13/20
SCHEMBL559345 SCHEMBL559345 0.48 13/20

Clinical trials — most relevant to GAS6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer PHASE2COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer PHASE2COMPLETED
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia. PHASE2COMPLETED
A Clinical Trial of TAA06 Injection in Advanced Solid Tumors PHASE1UNKNOWN
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) nanRECRUITING
Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage nanENROLLING_BY_INVITATION
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis nanACTIVE_NOT_RECRUITING
Genetic Determinants of Sudden Cardiac Death nanCOMPLETED
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma nanCOMPLETED
Biomarkers in Patients With Advanced Rhabdomyosarcoma nanCOMPLETED
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia nanCOMPLETED
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients nanCOMPLETED
Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH) nanACTIVE_NOT_RECRUITING
Biomarkers And Neurological Outcome in Neonates (BANON) nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Molecular Analysis of Thoracic Malignancies nanENROLLING_BY_INVITATION
Rational Therapeutics Based on Matched Tumor and Normal Tissue nanCOMPLETED
Identifying Methylation Biomarkers for Monitoring Bladder Tumors nanUNKNOWN
The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer nanNOT_YET_RECRUITING
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome nanRECRUITING
Biomarker Panel in Ovarian Torsion nanUNKNOWN
Molecular Basis of the Growth Axis in Short Stature nanCOMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients nanACTIVE_NOT_RECRUITING
Genetic Study in Patients With Stage II or Stage III Colon Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a GAS6 binder may also engage these)

ProteinNameSimilarity
Q61592 1.000 Q61592 →
Q63772 1.000 Q63772 →
Q0VCN6 0.984 Q0VCN6 →
Q9C0A0 0.983 Q9C0A0 →
P15306 0.982 P15306 →
Q53RD9 0.981 Q53RD9 →
Q8R4K8 0.980 Q8R4K8 →
A6NFU0 0.980 A6NFU0 →
Q6ZRI0 0.980 Q6ZRI0 →
A1A5Y0 0.979 A1A5Y0 →
Q501P1 0.979 Q501P1 →
Q9H4D0 0.978 Q9H4D0 →
Q8R553 0.978 Q8R553 →
P07204 0.978 P07204 →
Q71U07 0.978 Q71U07 →
A7E3C4 0.978 A7E3C4 →
Q0V8T0 0.977 Q0V8T0 →
DLK1 Protein delta homolog 1 0.977 landscape →
Q9NPY3 0.977 Q9NPY3 →
Q8K099 0.977 Q8K099 →
Q99JH7 0.977 Q99JH7 →
Q28146 0.977 Q28146 →
Q63374 0.977 Q63374 →
Q9WUA1 0.977 Q9WUA1 →
Q9JLC4 0.977 Q9JLC4 →
Q0VCG9 0.977 Q0VCG9 →
Q0V8S9 0.977 Q0V8S9 →
Q8VDA1 0.977 Q8VDA1 →
Q14114 0.977 Q14114 →
Q9W7R4 0.976 Q9W7R4 →